49 related articles for article (PubMed ID: 15505269)
1. Pulmonary actinomycosis complicating infliximab therapy for Crohn's disease.
Cohen RD; Bowie WR; Enns R; Flint J; Fitzgerald JM
Thorax; 2007 Nov; 62(11):1013-4. PubMed ID: 17965080
[TBL] [Abstract][Full Text] [Related]
2. Primary Cutaneous Nocardiosis in a Patient Taking Adalimumab Therapy for Crohn's Disease.
Desai M; Imran M; Irum A; Magadan J
Kans J Med; 2017 Feb; 10(1):20-21. PubMed ID: 29472961
[No Abstract] [Full Text] [Related]
3. Nocardia infections among immunomodulated inflammatory bowel disease patients: A review.
Abreu C; Rocha-Pereira N; Sarmento A; Magro F
World J Gastroenterol; 2015 Jun; 21(21):6491-8. PubMed ID: 26074688
[TBL] [Abstract][Full Text] [Related]
4. Primary facial cutaneous nocardiosis in a HIV patient and review of cutaneous nocardiosis in India.
Vijay Kumar GS; Mahale RP; Rajeshwari KG; Rajani R; Shankaregowda R
Indian J Sex Transm Dis AIDS; 2011 Jan; 32(1):40-3. PubMed ID: 21799576
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases.
Kaur N; Mahl TC
Dig Dis Sci; 2007 Jun; 52(6):1481-4. PubMed ID: 17429728
[TBL] [Abstract][Full Text] [Related]
6. Nocardia infection in kidney transplant recipients: case report and analysis of 66 published cases.
Yu X; Han F; Wu J; He Q; Peng W; Wang Y; Huang H; Li H; Wang R; Chen J
Transpl Infect Dis; 2011 Aug; 13(4):385-91. PubMed ID: 21824241
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone.
Singh SM; Rau NV; Cohen LB; Harris H
CMAJ; 2004 Oct; 171(9):1063-4. PubMed ID: 15505269
[TBL] [Abstract][Full Text] [Related]
8. [Primary cutaneous nocardia asteroides nocardiosis in an immunocompromised patient].
Marck Y; Meunier L; Perez C; Meynadier J
Ann Dermatol Venereol; 1995; 122(10):675-7. PubMed ID: 8687051
[TBL] [Abstract][Full Text] [Related]
9. [Opportunistic co-infection in a patient with Crohn's disease during infliximab (anti-TNFalpha) therapy].
Salavert M; Bastida G; Pemán J; Nos P
Rev Iberoam Micol; 2009 Sep; 26(3):213-7. PubMed ID: 19635442
[TBL] [Abstract][Full Text] [Related]
10. Risk of nocardial infections with anti-tumor necrosis factor therapy.
Ali T; Chakraburtty A; Mahmood S; Bronze MS
Am J Med Sci; 2013 Aug; 346(2):166-8. PubMed ID: 23531994
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary nocardiosis in an adolescent patient with Crohn's disease treated with infliximab: a serious complication of TNF-alpha blockers.
Verma R; Walia R; Sondike SB; Khan R
W V Med J; 2015; 111(3):36-9. PubMed ID: 26050296
[TBL] [Abstract][Full Text] [Related]
12. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.
Lichtenstein GR; Feagan BG; Cohen RD; Salzberg BA; Diamond RH; Chen DM; Pritchard ML; Sandborn WJ
Clin Gastroenterol Hepatol; 2006 May; 4(5):621-30. PubMed ID: 16678077
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis.
Menon KV; Stadheim L; Kamath PS; Wiesner RH; Gores GJ; Peine CJ; Shah V
Am J Gastroenterol; 2004 Feb; 99(2):255-60. PubMed ID: 15046213
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]